Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00405899|
Recruitment Status : Completed
First Posted : November 30, 2006
Last Update Posted : May 31, 2010
|Condition or disease|
|Allergy Seasonal Allergic Rhinitis Perennial Allergic Rhinitis|
This study will consist of five visits. Visit 1 will occur after subjects complete an initial clinical evaluation for allergy at this site. Subjects will select their treatment (allergy immunotherapy as compared to standard medical care) prior to enrollment in this study.
Visit 1 will include informed consent, review of inclusion and exclusion criteria and phlebotomy for the determination of serum interferon-gamma levels. At the end of this visit, diary cards to capture the frequency of symptoms of viral respiratory infections will be distributed. Visits 2-5 will occur 3, 6, 9 and 12 months after visit 1 and will include review/exchange of diary cards, and phlebotomy for determination of serial serum interferon-gamma levels.
|Study Type :||Observational|
|Estimated Enrollment :||20 participants|
|Official Title:||Pilot Study of Allergy Immunotherapy and Prevention of Viral Respiratory Infections|
|Study Start Date :||October 2006|
|Study Completion Date :||December 2009|
Patients starting immunotherapy
Patients being treated using methods other than immunotherapy
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00405899
|United States, Pennsylvania|
|Allegheny General Hospital|
|Pittsburgh, Pennsylvania, United States, 15212|
|Principal Investigator:||Deborah Gentile, MD||West Penn Allegheny Health System|